590021 Stock Overview
Manufactures and sells technical grade pesticides and intermediates in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Bharat Rasayan Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹11,637.60 |
| 52 Week High | ₹14,281.35 |
| 52 Week Low | ₹8,351.05 |
| Beta | 0.63 |
| 11 Month Change | 12.93% |
| 3 Month Change | -10.97% |
| 1 Year Change | 27.82% |
| 33 Year Change | 21.50% |
| 5 Year Change | 93.03% |
| Change since IPO | 40,733.68% |
Recent News & Updates
Recent updates
Shareholder Returns
| 590021 | IN Chemicals | IN Market | |
|---|---|---|---|
| 7D | 2.8% | -0.8% | 0.5% |
| 1Y | 27.8% | 10.7% | 27.5% |
Return vs Industry: 590021 exceeded the Indian Chemicals industry which returned 10.7% over the past year.
Return vs Market: 590021 matched the Indian Market which returned 27.5% over the past year.
Price Volatility
| 590021 volatility | |
|---|---|
| 590021 Average Weekly Movement | 7.3% |
| Chemicals Industry Average Movement | 5.6% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 590021 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 590021's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 816 | Rajender Gupta | www.bharatgroup.co.in |
Bharat Rasayan Limited manufactures and sells technical grade pesticides and intermediates in India. The company offers insecticides, herbicides, fungicides, and intermediates. It also exports its products through multinational agrochemical companies and other traders.
Bharat Rasayan Limited Fundamentals Summary
| 590021 fundamental statistics | |
|---|---|
| Market cap | ₹48.90b |
| Earnings (TTM) | ₹1.58b |
| Revenue (TTM) | ₹11.53b |
30.6x
P/E Ratio4.2x
P/S RatioIs 590021 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 590021 income statement (TTM) | |
|---|---|
| Revenue | ₹11.53b |
| Cost of Revenue | ₹7.45b |
| Gross Profit | ₹4.08b |
| Other Expenses | ₹2.50b |
| Earnings | ₹1.58b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 379.47 |
| Gross Margin | 35.38% |
| Net Profit Margin | 13.68% |
| Debt/Equity Ratio | 5.9% |
How did 590021 perform over the long term?
See historical performance and comparison